{
    "code": "02023649",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02023649",
    "time": "2023-03-03 03:25:32",
    "許可證字號": "衛署藥輸字第023649號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "117\/02\/06",
    "發證日期": "92\/02\/06",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA00202364909",
    "中文品名": "複必康平錠80\/12.5毫克",
    "英文品名": "MICARDIS PLUS TABLETS 80\/12.5 MG",
    "適應症": "原發性高血壓、無法單獨以TELMISARTAN或HYDROCHLORTHIAZIDE得到適當血壓控制的病患。",
    "劑型": "110錠劑",
    "包裝": "2-1000錠鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "TELMISARTAN, HYDROCHLOROTHIAZIDE (EQ TO 3,4-DIHYDROCHLOROTHIAZIDE)",
    "限制項目": "02輸　入",
    "申請商名稱": "1405201100  臺灣百靈佳殷格翰股份有限公司",
    "申請商地址": "台北市中山區民生東路三段2號12樓",
    "主製造廠": [
        {
            "製造廠名稱": "FGR0033200  BOEHRINGER INGELHEIM HELLAS SINGLE MEMBER S.A.",
            "製造廠廠址": "5TH KM PAIANIA-MARKOPOULO, KOROPI ATTIKI, 19441, GREECE",
            "製造廠公司地址": "",
            "製造廠國別": "GREECE",
            "製程": "成品及包裝廠"
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "FDE0021000  BOEHRINGER INGELHEIM PHARMA GMBH &amp; CO. KG.",
            "製造廠廠址": "BINGER STRASSE 173, 55216 INGELHEIM AM RHEIN GERMANY",
            "製造廠公司地址": "",
            "製造廠國別": "GERMANY",
            "製程": "製粒"
        },
        {
            "製造廠名稱": "FDE0299000  BOEHRINGER INGELHEIM INTERNATIONAL GMBH",
            "製造廠廠址": "BINGER STRASSE 173, 55216 INGELHEIM AM RHEIN, GERMANY",
            "製造廠公司地址": "",
            "製造廠國別": "GERMANY",
            "製程": "許可證持有者"
        }
    ],
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2408005600",
            "成分名稱": "TELMISARTAN",
            "含量描述": "",
            "含量": "80.0000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "4028100600",
            "成分名稱": "HYDROCHLOROTHIAZIDE (EQ TO 3,4-DIHYDROCHLOROTHIAZIDE)",
            "含量描述": "",
            "含量": "12.5000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "MI 80Plus-104-09-10(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023649&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "02-MI Plus_13_CS_clean (20210304)-110-03-15.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023649&Seq=007&Type=9"
        },
        {
            "title": "MI Plus 80 blister-109-12-04(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023649&Seq=007&Type=8"
        },
        {
            "title": "80+12.5mg-FBP043306-002-108-07-18(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023649&Seq=006&Type=8"
        },
        {
            "title": "020236490007___20121113.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023649&Seq=004&Type=8"
        }
    ]
}